PMA device
Duo Venous Stent System
Philips Image Guided Therapy Corporation · Stent, Iliac Vein (QAN, Class III) · First FDA decision Dec 26, 2023, newest Feb 12, 2026Pulmonary embolism and deep vein thrombosisVaricose veins and venous insufficiency
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
8
Naming "Duo Venous"
MAUDE reports
2
Brand "Duo Venous", since 2015
PubMed studies
1
Mentioning "Duo Venous"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Duo Venous Stent System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- Duo Venous Stent SystemPMA supplement
P230021-S003 · Decided Feb 12, 2026 · 139 days after receipt · Normal 180 Day Track No User Fee
Device type: Stent, iliac vein (QAN) · Cardiology
- Duo Venous Stent SystemPMA supplement
P230021-S002 · Decided Nov 18, 2025 · 110 days after receipt · Normal 180 Day Track No User Fee
Device type: Stent, iliac vein (QAN) · Cardiology
P230021 · Decided Dec 26, 2023 · 176 days after receipt
Device type: Stent, iliac vein (QAN) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Duo Venous", any status and sponsor, newest update first.
HepQuant, LLCNot on our public-company list
NCT07473817 · 200 participants (planned) · Start Sep 18, 2026 · Primary completion Feb 18, 2027
Device: HepQuant DuO Test · For: Healthy Adult Participants; Liver Disease Chronic
Vesper Medical, Inc.Not on our public-company list
NCT04580160 · 162 participants · Start Nov 30, 2020 · Primary completion Dec 3, 2022
Device: Duo Venous Stent System · For: May-Thurner Syndrome; Deep Vein Thrombosis; Chronic Venous Insufficiency
Sites: Orange, California; Palo Alto, California; Darien, Connecticut · 30 sites in all
- The Use of Injectable-Platelet Rich Fibrin (i-PRF) in the Lower Third Molar ExtractionStatus unknown
University of NaplesAcademic, hospital or other
NCT06073535 · 40 participants · Start Feb 27, 2023 · Primary completion Sep 4, 2023
Device: i-PRF · For: Molar, Third; Postoperative Complications
Sites: Naples, Italy
5 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Duo Venous", and for the whole product code for context.
This brand
2 reports: 1 malfunction, 0 injury, 1 death
Whole product code QAN
1,334 reports: 763 malfunction, 563 injury, 8 death
Newest reports for this brand
- PROTEK DUO VENOUS CANNULAMalfunction
2531527-2025-20003 · Received Jun 18, 2025 · Event dated May 18, 2025
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF)
Device problem as coded: Partial Blockage
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2531527-2025-20002 · Received Jun 16, 2025 · Event dated Jan 1, 2025
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF)
Device problem as coded: Patient Device Interaction Problem
Patient problem as coded: Hypovolemic Shock
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Duo Venous"[tiab]. The summary above synthesizes these.
- The VIVID trial 12-month outcomes of the venous stent for the iliofemoral vein using the Duo venous stent system.
Razavi M, Lichtenberg M, Desai K, et al. · J Vasc Surg Venous Lymphat Disord · 2025Multicenter Study, Clinical Trial
Other devices of this type
Also filed under product code QAN.
- VICI VENOUS STENT SystemBoston Scientific Corporation · PMA 2021
- Zilver Vena Venous Self-Expanding StentCook Ireland, Ltd. · PMA 2024
- Abre Venous Self-expanding Stent SystemMedtronic Vascular, Inc. · PMA 2022
- Venovo Venous Stent SystemBard Peripheral Vascular, Inc. · PMA 2021
- Venous WallstentBoston Scientific Corporation · PMA 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.